Merck
Stay current with all the latest and breaking news about Merck, compare headlines and perspectives between news sources on stories happening today. In total, 29 stories have been published about Merck which Ground News has aggregated in the past 3 months.Stay current with all the latest and breaking news about Merck, compare headlines and perspectives between news sources on stories happening today. In total, 29 stories have been published about Merck which Ground News has aggregated in the past 3 months.
Covered Most By
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Merck News
Latest News Stories
Merck · ParisPARIS: An anti-Covid drug widely used across the world may have caused mutations in the virus, researchers said on Monday (Tuesday in Manila), but there was no evidence that the changes had led to more dangerous variants.Pharmaceutical giant Merck's antiviral pill molnupiravir was one of the earliest treatments rolled out during the pandemic to prevent Covid becoming more severe in vulnerable people.The drug, which is taken orally over a five-da…See the Story
Anti-Covid drug may be behind virus mutations
100% Right coverage: 1 sources
Merck · RomaniaMolnupiravir, the anti-COVID-19 pill developed by Merck, is at risk of aggravating the pandemic? Several researchers say that this treatment contributes to the emergence of mutations of the new coronavirus, with a risk that remains theoretical for now: the appearance of dangerous variants, AFP and Agerpres informs.See the Story
Anti-COVID pill developed by Merck accused of accelerating coronavirus mutations
100% Left coverage: 1 sources
BusinessTwo late-stage trials of a treatment for a certain type of non-small lung cancer failed to meet their primary goals. The companies said they would continue to push ahead with their research. Merck's stock is down 3.8% in the year to date, while the S&P 500 SPX has gained 12.8%.See the Story
Merck and Eisai say two lung-cancer trials failed to meet their main goals
100% Center coverage: 2 sources
MerckMerck is a prominent multinational pharmaceutical and life sciences corporation. Its brand value increased to an impressive $5.8 billion, marking a remarkable increase of $1.2 billion compared to the prior year. Merck has exhibited robust growth both in terms of top-line and bottom-line performance, primarily driven by its blockbuster oncology drug, Keytruda.See the Story
Merck: Secure A Safe 8% Annualized Return For The Next Decade (NYSE:MRK)
100% Right coverage: 1 sources
Artificial Intelligence · SeoulMerck, a German science and technology company, noted that the semiconductor industry should embrace AI and machine learning for digital transformation, according to its Korean unit Wednesday.See the Story
Merck emphasizes digitalization in the semiconductor market
100% Left coverage: 1 sources
